摘要
背景:尽管凝聚素(一种参与脂质代谢、β-淀粉样蛋白清除和髓鞘形成的蛋白质)与有阿尔茨海默病风险的老年人样本中的灰质萎缩有关,但研究探索与白质 (WM) 微观和宏观的关联- 结构标记在很大程度上受到限制。 目的:本研究探讨了血清凝聚素蛋白水平与 WM 微观和宏观结构标志物之间的关联,并阐明了 WM 分数各向异性 (FA) 的变化是否与受过良好教育的老年人的种族同质样本中的功能能力相关。没有痴呆症的成年人。 方法:参与者接受了磁共振成像 (MRI) 脑部检查和抽血,并完成了基于表现的日常功能测量。使用针对年龄、性别、APOE e4 阳性和血管风险进行调整的多元线性回归来探索血清凝聚素与 WM 指标的关联,并阐明 WM 微观结构与日常功能之间的潜在联系。 结果:较高的血清凝聚素与一些丘脑皮质(前和后内囊,后丘脑辐射;ss = -.32 至 -.37,ps = .01 至 .02)和相关纤维束(外囊,上纵束;ss = -.32 至 -.40,ps = .02)。血清凝集素与白质高信号体积无关(s = .14,p = .28),但几个 WM 束的更高 FA 与独立生活量表的更好表现相关(ss = .37 至 .53,ps = .006 至 .03)。 结论:血清凝集素与 WM 指标差异相关,WM 微观结构与日常功能相关。
关键词: 轻度认知障碍、血清凝聚素、DTI、白质高信号、白质微结构、神经退行性疾病。
Current Alzheimer Research
Title:White Matter Microstructure is Associated with Serum Clusterin and Everyday Functioning in a Sample of Nondemented Older Adults
Volume: 18 Issue: 14
关键词: 轻度认知障碍、血清凝聚素、DTI、白质高信号、白质微结构、神经退行性疾病。
摘要:
Background: Although clusterin-a protein involved in lipid metabolism, amyloid beta clearance, and myelination-has been linked to gray matter atrophy within samples of older adults at risk for Alzheimer’s disease, research exploring associations with white matter (WM) micro- and macro- structural markers are largely limited.
Objective: The current study explored associations between serum clusterin protein levels and WM micro- and macro- structural markers, and clarified whether variations in WM fractional anisotropy (FA) were associated with functional abilities within in a racially homogenous sample of relatively well-educated older adults free of dementia.
Methods: Participants underwent magnetic resonance imaging (MRI) brain exams and a blood draw and completed a performance-based measure of everyday functioning. Multiple linear regression adjusting for age, sex, APOE e4 positivity, and vascular risk were used to explore serum clusterin associations with WM metrics, as well clarify potential links between WM microstructure and everyday functioning.
Results: Higher serum clusterin was associated with lower FA in several thalamocortical (anterior and posterior internal capsule, posterior thalamic radiation; ßs = -.32 to -.37, ps = .01 to .02) and association fiber tracts (external capsule, superior longitudinal fasciculus; ßs = -.32 to -.40, ps = .02). Serum clusterin was not associated with white matter hyperintensity volume (ß = .14, p = .28), but higher FA of several WM tracts was associated with better performance on the Independent Living Scale (ßs = .37 to .53, ps = .006 to .03).
Conclusions: Serum clusterin is differentially associated with WM metrics, and WM microstructure is associated with everyday functioning.
Export Options
About this article
Cite this article as:
White Matter Microstructure is Associated with Serum Clusterin and Everyday Functioning in a Sample of Nondemented Older Adults, Current Alzheimer Research 2021; 18 (14) . https://dx.doi.org/10.2174/1567205019666211227102350
DOI https://dx.doi.org/10.2174/1567205019666211227102350 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Progress in Detection of Insomnia Sleep Disorder: A Comprehensive Review
Current Drug Targets Driving Cellular Plasticity and Survival Through the Signal Transduction Pathways of Metabotropic Glutamate Receptors
Current Neurovascular Research Critical Role of the Endocannabinoid System in the Regulation of Food Intake and Energy Metabolism, with Phylogenetic, Developmental, and Pathophysiological Implications
Endocrine, Metabolic & Immune Disorders - Drug Targets [General Articles] Natriuretic Peptides in Alcohol Withdrawal: Central and Peripheral Mechanisms
Current Medicinal Chemistry Gene Therapy for Parkinsons and Alzheimers Diseases: from the Bench to Clinical Trials
Current Pharmaceutical Design Caffeine: Cognitive and Physical Performance Enhancer or Psychoactive Drug?
Current Neuropharmacology Use of Push-Pull Superfusion Technique for Identifying Neurotransmitters Involved in Brain Functions: Achievements and Perspectives
Current Neuropharmacology Ion Channel Defects in Idiopathic Epilepsies
Current Pharmaceutical Design The Growth Hormone Secretagogue Receptor (Ghs-R)
Current Pharmaceutical Design The Role of Oxidative Stress in Depressive Disorders
Current Pharmaceutical Design Recent Progress in the Development of Agonists and Antagonists for Melatonin Receptors
Current Medicinal Chemistry State Dissociation, Human Behavior, and Consciousness
Current Topics in Medicinal Chemistry Impaired Translation of Spatial Representation in Young Onset Alzheimer’s Disease Patients
Current Alzheimer Research Natural Products Based Ayurvedic Formulations: Chemical Cons tituents and Treatment in Neurodegenerative Disordersǂ
Mini-Reviews in Organic Chemistry Amantadine, Apomorphine and Zolpidem in the Treatment of Disorders of Consciousness
Current Pharmaceutical Design Regulation of Brain Reward by the Endocannabinoid System: A Critical Review of Behavioral Studies in Animals
Current Pharmaceutical Design Suicide in Parkinson’s Disease: A Systematic Review
CNS & Neurological Disorders - Drug Targets Primary and Secondary Insomnia: Prevalence, Causes and Current Therapeutics
Current Medicinal Chemistry - Central Nervous System Agents Therapeutic Utilisations of Vasopressin and Oxytocin in Mood Disorders
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) On the Relationship Between the Light/Dark Cycle, Melatonin and Oxidative Stress
Current Pharmaceutical Design